India's Wockhardt slumps after FDA criticisms of new drug plant

MUMBAI (Reuters) - Indian drugmaker Wockhardt Ltd said the U.S. Food and Drug Administration (FDA) had issued a notice outlining manufacturing violations at its Shendra plant in western India, delaying the company's plans to rebuild its battered U.S. business.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro